{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T23:40:36Z","timestamp":1709941236934},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/bf02893414","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T22:55:16Z","timestamp":1231541716000},"page":"211-215","source":"Crossref","is-referenced-by-count":4,"title":["Clinical findings and HER-2\/neu gene amplification status of breast carcinoma patients"],"prefix":"10.1007","volume":"12","author":[{"given":"Feride Iffet","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerrin","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut Can","family":"Yagmurdur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Belgin","family":"Atac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binnaz Handan","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamdi","family":"Karakayali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beyhan","family":"Demirhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Haberal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02893414_CR1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/01.LAB.0000024360.48464.A4","volume":"82","author":"N Dandachi","year":"2002","unstructured":"Dandachi N, Dietze O, Hauser-Kronberger C: Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma. Lab Invest 82: 1007\u20131014, 2002.","journal-title":"Lab Invest"},{"key":"BF02893414_CR2","unstructured":"Mariani SM: Conference report \u2014 breast cancer markers: What Next? Medscape General Medicine 5: 2003."},{"key":"BF02893414_CR3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/path.1313","volume":"199","author":"M Dowsett","year":"2003","unstructured":"Dowsett M, Bartlett J, Ellis IO et al: Correlation between immunohistochemistry (HercepTest) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol 199: 418\u2013423, 2003.","journal-title":"J Pathol"},{"key":"BF02893414_CR4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1034\/j.1600-0463.2003.t01-1-1110210.x","volume":"111","author":"T Sauer","year":"2003","unstructured":"Sauer T, Wiedswang G, Boudjema G et al: Assessment of HER-2\/neu overexpression and\/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice? APMIS 111: 444\u2013450, 2003.","journal-title":"APMIS"},{"key":"BF02893414_CR5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1309\/FUQH92B039025LHG","volume":"121","author":"D Varshney","year":"2004","unstructured":"Varshney D, Zhou YY, Geller SA et al: Determination of HER-2 status and chromosome 17 polisomy in breast carcinomas comparing HercepTest and PathVysion FISH assay. Am J Clin Pathol 121:70\u201377, 2004.","journal-title":"Am J Clin Pathol"},{"key":"BF02893414_CR6","doi-asserted-by":"crossref","unstructured":"Simeone A: Detection of mRNA in tissue section with radiolabelled riboprobes. In: In Situ Hybridization 2nd ed (Ed: DG Wilkinson), The Practical Approach Series, Oxford University Press, 1998, pp 69\u201386.","DOI":"10.1093\/oso\/9780199636594.003.0003"},{"key":"BF02893414_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02893855","volume":"11","author":"Z Yilmaz","year":"2005","unstructured":"Yilmaz Z, Sahin FI, Atalay B, et al: Chromosome 1p36 and 22qter deletions in paraffin block sections of intracranial meningiomas. Pathol Oncol Res 11: 224\u2013228, 2005.","journal-title":"Pathol Oncol Res"},{"key":"BF02893414_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cancergencyto.2004.03.005","volume":"155","author":"MG Tibiletti","year":"2004","unstructured":"Tibiletti MG: Specificity of interphase fluorescence in situ hybridization for detection of chromosome aberrations in tumor pathology. Cancer Genet Cytogenet 155: 143\u2013148, 2004.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF02893414_CR9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0019-509X.13769","volume":"41","author":"G Sumita","year":"2004","unstructured":"Sumita G, Zoran G, Amin M et al: FISH for HER-2\/neu in breast cancer: Standardization makes the difference! Ind J Cancer 41: 152\u2013158, 2004.","journal-title":"Ind J Cancer"},{"key":"BF02893414_CR10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/annonc\/mdf217","volume":"13","author":"C Bozzetti","year":"2002","unstructured":"Bozzetti C, Nizzoli R, Guazzi A et al: HER-2\/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer. Ann Oncol 13: 1398\u20131403, 2002.","journal-title":"Ann Oncol"},{"key":"BF02893414_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/path.1354","volume":"199","author":"J Bartlett","year":"2003","unstructured":"Bartlett J, Mallon E, Cooke T: The clinical evaluation of HER-2 status: which test to use? J Pathol 199: 411\u2013417, 2003.","journal-title":"J Pathol"},{"key":"BF02893414_CR12","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2000.18.21.3651","volume":"18","author":"G Pauletti","year":"2000","unstructured":"Pauletti G, Dandekar S, Rong HM et al: Assessment of methods for tissue-based detection of the HER-2\/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18: 3651\u20133664, 2000.","journal-title":"J Clin Oncol"},{"key":"BF02893414_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1634\/theoncologist.8-4-307","volume":"8","author":"JS Ross","year":"2003","unstructured":"Ross JS, Fletcher JA, Linette GP et al: The HER-2\/neu gene and protein in breast cancer 2003: Biomarker and target of therapy. The Oncologist 8: 307\u2013325, 2003.","journal-title":"The Oncologist"},{"key":"BF02893414_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1054\/brst.2000.0225","volume":"10","author":"MA Climent","year":"2001","unstructured":"Climent MA, Segui MA, Peir\u00f3 G et al: Prognostic value of HER-2\/neu and p53 expression in node-positive breast cancer. HER-2\/neu effect on adjuvant tamoxifen treatment. The Breast 10: 67\u201377, 2001.","journal-title":"The Breast"},{"key":"BF02893414_CR15","first-page":"8452","volume":"61","author":"M Dowsett","year":"2001","unstructured":"Dowsett M, Harper-Wynne C, Boeddinghaus I et al: HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. Cancer Res 61: 8452\u20138458, 2001.","journal-title":"Cancer Res"},{"key":"BF02893414_CR16","first-page":"7","volume":"4","author":"RM Elledge","year":"1998","unstructured":"Elledge RM, Green S, Ciocca D et al: HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. Clin Cancer Res 4: 7\u201312, 1998.","journal-title":"Clin Cancer Res"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02893414\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T23:07:10Z","timestamp":1709939230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02893414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BF02893414"],"URL":"https:\/\/doi.org\/10.1007\/bf02893414","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}